Mereo BioPharma Group plc Total Liabilities

Latest as of December 2025: €5.00 Million EUR ≈ $5.85 Million USD

Mereo BioPharma Group plc total liabilities. Based on the latest financial reports, Mereo BioPharma Group plc (MAH0) has total liabilities worth €5.00 Million EUR (≈ $5.85 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Mereo BioPharma Group plc liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Mereo BioPharma Group plc (2016–2025)

Total liabilities of Mereo BioPharma Group plc from 2016 to 2025. This chart illustrates how Mereo BioPharma Group plc's total liabilities have evolved over time, based on quarterly financial data.

Mereo BioPharma Group plc Competitors by Total Liabilities

The table below lists competitors of Mereo BioPharma Group plc ranked by their total liabilities.

Company	Country	Total Liabilities
Jeil Technos Co.Ltd KQ:038010	Korea	₩45.71 Billion
Datron AG XETRA:DAR	Germany	€38.45 Million
Ironbark Capital Ltd AU:IBC	Australia	AU$1.83 Million
Poulaillon SA PA:ALPOU	France	€51.50 Million
Chow Steel Industries Public Company Limited BK:CHOW	Thailand	฿674.73 Million
Bowim S.A. WAR:BOW	Poland	zł286.49 Million
TDb Split Corp TO:XTD	Canada	CA$47.56 Million
Hitech Group Australia Ltd AU:HIT	Australia	AU$6.60 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Mereo BioPharma Group plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Mereo BioPharma Group plc.

Liquidity & Leverage Metrics

Mereo BioPharma Group plc Total Liabilities Ratios Explained

Mereo BioPharma Group plc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	10.46	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.12	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Mereo BioPharma Group plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Mereo BioPharma Group plc (2016–2025)

The table below shows the annual total liabilities of Mereo BioPharma Group plc from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	€5.00 Million ≈ $5.85 Million	-67.57%
2024-12-31	€15.42 Million ≈ $18.03 Million	-3.39%
2023-12-31	€15.96 Million ≈ $18.66 Million	-39.10%
2022-12-31	€26.21 Million ≈ $30.64 Million	-31.77%
2021-12-31	€38.41 Million ≈ $44.91 Million	-50.70%
2020-12-31	€77.92 Million ≈ $91.09 Million	+68.68%
2019-12-31	€46.19 Million ≈ $54.00 Million	+33.87%
2018-12-31	€34.51 Million ≈ $40.34 Million	+1.93%
2017-12-31	€33.85 Million ≈ $39.58 Million	+350.87%
2016-12-31	€7.51 Million ≈ $8.78 Million	--

About Mereo BioPharma Group plc

F:MAH0 Germany Biotechnology

Market Cap

$47.40 Million

€40.54 Million EUR

Market Cap Rank

#23352 Global

#2044 in Germany

Share Price

€0.25

Change (1 day)

-2.31%

52-Week Range

€0.20 - €1.96

All Time High

€4.48